Loading...

argenx SE

ARGXNASDAQ
HealthcareBiotechnology
$573.26
$-7.69(-1.32%)

argenx SE ARGX Peers

See (ARGX) competitors and their performances in Stock Market.

Peer Comparison Table: Biotechnology Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
ARGX$573.26-1.32%35B35.00$16.38N/A
VRTX$441.84-1.18%113.5B-115.36-$3.83N/A
REGN$489.52-19.14%52B12.44$39.36+0.36%
SGEN$228.74-0.07%43.2B-57.19-$4.00N/A
ALNY$304.56+3.98%39.7B-140.35-$2.17N/A
BNTX$95.81-4.43%23B-26.39-$3.63N/A
BGNE$184.71+0.49%20.2B-22.55-$8.19N/A
DNA-WT$0.27-2.76%18.7BN/AN/AN/A
RPRX$32.88+0.74%18.5B13.42$2.45+2.61%
UTHR$318.85-0.47%14.4B12.71$25.09N/A
Showing 1 to 10 of 100 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

ARGX vs VRTX Comparison

ARGX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ARGX stands at 35B. In comparison, VRTX has a market cap of 113.5B. Regarding current trading prices, ARGX is priced at $573.26, while VRTX trades at $441.84.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ARGX currently has a P/E ratio of 35.00, whereas VRTX's P/E ratio is -115.36. In terms of profitability, ARGX's ROE is +0.16%, compared to VRTX's ROE of -0.06%. Regarding short-term risk, ARGX is more volatile compared to VRTX. This indicates potentially higher risk in terms of short-term price fluctuations for ARGX.

Stock Price Comparison

Loading...

Frequently Asked Questions